The consensus price target for Emergent BioSolutions has shifted from US$15 to US$12, with the modeled fair value sitting at US$12 per share. Analysts link this move to reduced earnings expectations ...
The average one-year price target for Emergent BioSolutions (NYSE:EBS) has been revised to $12.24 / share. This is a decrease of 11.11% from the prior estimate of $13.77 dated February 21, 2026. The ...
The above button links to Coinbase. Yahoo Finance is not a broker-dealer or investment adviser and does not offer securities or cryptocurrencies for sale or facilitate trading. Coinbase pays us for ...
Fintel reports that on December 16, 2025, HC Wainwright & Co. reiterated coverage of Emergent BioSolutions (NYSE:EBS) with a Buy recommendation. As of December 6, 2025, the average one-year price ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results